FCS has a national reputation for excellence that is reflected in exceptional and compassionate patient care, innovative clinical research, cutting-edge technologies, and advanced treatments. With nearly 100 locations, FCS serves patients throughout Florida. we are committed to providing world-class cancer care in community-based settings close to home.
Lutathera® is a targeted drug therapy approved for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) that are positive for the hormone receptor somatostatin. Learn More.
Unveiling the truth about smokeless tobacco and cancer. Learn about the dangers of smokeless tobacco and the potential health risks it poses, including an increased risk of cancer.
Comments